Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Atlantis › NPI 1740488519
Physician

J.F.K. Pediatrics INC.

J.F.K. Pediatrics INC. was paid $3.78M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.

33Billing provider infoJ.F.K. PEDIATRICS INC.
ATLANTIS, FL 33462
33aNPI1740488519assigned 07/03/2007
33bProvider typePediatrics Physician
28Total paid$3.78M
24GClaims136,274
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Florida

Rank by total paid#87 of 971
Median peer was paid$238K
This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,241$31K
201921,701$514K
202016,755$515K
202123,105$762K
202228,654$898K
202330,501$835K
2024incomplete14,317$224K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 31% 11,166 10,288 $1.18M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 25% 13,678 12,574 $932K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 8.5% 3,733 3,619 $323K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 5.8% 2,490 2,409 $219K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 4.6% 2,382 2,251 $173K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 4.4% 6,592 6,255 $166K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4.3% 1,791 1,734 $161K
90461 3.4% 3,391 3,263 $130K
90460 Immunization administration through 18 years of age via any route, first or only component 2.6% 11,800 7,529 $97K
92553 2.2% 7,542 7,275 $82K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2.0% 14,805 7,427 $74K
97802 1.9% 6,782 6,491 $72K
60 more codes
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.0% 8,420 $40K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 643 $29K
99188 <1% 2,147 $15K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 97 $13K
90472 Immunization administration, each additional vaccine (list separately) <1% 749 $11K
96127 <1% 8,536 $7K
36415 Collection of venous blood by venipuncture <1% 4,323 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,307 $7K
99383 <1% 79 $5K
99381 <1% 53 $4K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 2,753 $4K
90671 <1% 113 $3K
85018 <1% 1,965 $2K
90651 <1% 905 $2K
96161 <1% 1,507 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 106 $2K
99401 <1% 242 $1K
91300 <1% 94 $1K
90670 <1% 1,689 $1K
90716 <1% 375 $1K
90698 <1% 856 $1K
90686 <1% 2,928 $1K
92567 <1% 159 $1K
99441 <1% 20 $900.15
99384 <1% 17 $843.18
0002A <1% 31 $840.69
87581 <1% 96 $786.02
87486 <1% 97 $764.40
90707 <1% 327 $653.61
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 104 $646.84
99173 <1% 966 $606.60
90474 <1% 149 $588.00
0001A <1% 38 $559.94
0071A <1% 13 $519.95
99382 <1% 14 $492.07
0072A <1% 12 $479.77
90700 <1% 773 $361.12
90633 <1% 960 $330.25
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 95 $287.02
90710 <1% 86 $250.21
90619 <1% 157 $226.88
81003 <1% 163 $194.36
90648 <1% 505 $169.39
90713 <1% 508 $159.85
90621 <1% 28 $85.08
90696 <1% 145 $56.18
90677 <1% 170 $42.54
90685 <1% 60 $37.44
94664 <1% 53 $17.02
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 1,501 $14.18
90734 <1% 259 $14.18
85013 <1% 654 $9.90
90744 0% 867 $0.00
90680 0% 850 $0.00
A7015 Aerosol mask, used with dme nebulizer 0% 18 $0.00
91307 0% 45 $0.00
90620 0% 14 $0.00
90656 0% 57 $0.00
90715 0% 206 $0.00
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 0% 18 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKONOWITZ-SIRKIN, JULIE (PRESIDENT)